Injection of Bone Marrow Cell Extract Into Infarcted Hearts Results in Functional Improvement Comparable to Intact Cell Therapy

Abstract

We compared therapeutic benefits of intramyocardial injection of unfractionated bone marrow cells (BMCs) versus BMC extract as treatments for myocardial infarction (MI), using closed-chest ultrasound-guided injection at a clinically relevant time post-MI. MI was induced in mice and the animals treated at day 3 with either: (i) BMCs from green fluorescent protein (GFP)-expressing mice (n = 14), (ii) BMC extract (n = 14), or (iii) saline control (n = 14). Six animals per group were used for histology at day 6 and the rest followed to day 28 for functional analysis. Ejection fraction was similarly improved in the BMC and extract groups versus control (40.6 +/- 3.4 and 39.1 +/- 2.9% versus 33.2 +/- 5.0%, P < 0.05) with smaller scar sizes. At day 6 but not day 28, both therapies led to significantly higher capillary area and number of arterioles versus control. At day 6, BMCs increased the number of cycling cardiomyocytes (CMs) versus control whereas extract therapy resulted in significant reduction in the number of apoptotic CMs at the border zone (BZ) versus control. Intracellular components within BMCs can enhance vascularity, reduce infarct size, improve cardiac function, and influence CM apoptosis and cycling early after therapy following MI. Intact cells are not necessary and death of implanted cells may be a major component of the benefit.

Function of mesenchymal stem cells following loading of gold nanotracers

“…4 Many investigators have suggested delivering stem cells to an injury site (eg, myocardial infarction) in order to promote wound healing and retain normal physiological f unction. [2][3][4]25,26 However, it is not clear if the MSCs implanted within the gels are actively participating in neovascularization in vivo, and, if so, what the specific role of the delivered MSCs is in neovascularization. Thus, we are proposing to load MSCs …”

Use of Stem Cells in Heart Failure Treatment: Where We Stand and Where We Are Going

“…47 some authors suggest that the beneficial action of stem cells depends on their ability to recruit lymphohistiocytic compounds more than on cell differentiation to new cardiomyocytes, and that the most important positive effects are related to the death of implanted cells in the site of transplantation rather than the intact stem cells by themselves (Figure 2). 48 this hypothesis could be well established by clinical trials that have shown how intracoronary stem cell transplantation can lead to improved ventricular remodeling and function, exercise tolerance, and long-term survival in patients with initial higher intramyocardial homing, despite low cell retention at the end of the study. [37][38] one of the main factors affecting the efficacy of stem cell therapies seems to be the number of viable cells that achieve nesting on the affected myocardium.…”

Stem cells: novel players in the treatment of erectile dysfunction

“…104 Additionally, and perhaps most striking, the beneficial effects of BMSCs have been replicated using cell-free lysates and conditioned BMSC culture medium. 110,111 Muscle-derived stem cells (MDSCs) MDSCs are ASCs found in muscle tissues. They are easily isolated from autologous muscle biopsies, and they pose low immunogenic and Stem cells and erectile dysfunction HY Zhang et al 150 carcinogenic risks.…”